Chromatographic methods for the isolation of, and refolding of proteins from, Escherichia coli inclusion bodies

Protein Expression and Purification

Volumn 25, Issue 1, 2002, Pages 174-179

  Gu, Zhenyu ^a   Weidenhaupt, Marianne ^b   Ivanova, Natalia ^c   Pavlov, Michail ^c   Xu, Bingze ^d   Su, Zhi Guo ^a   Janson, Jan Christer ^d  

^a INSTITUTE OF PROCESS ENGINEERING   (China)

^b INSTITUT DE BIOLOGIE STRUCTURALE   (France)

^c UPPSALA UNIVERSITY   (Sweden)

^d Center for Surface Biotechnology   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI; TRIXIS;

EID: 0036922141     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.2002.1624     Document Type: Article

References (14)

1. Rudolph, R., and Lilie, H. (1996) In vitro folding of inclusion body proteins. FASEB J. 10, 49-56.
2. Al Moudallal, Z., Briand, J. P., and Van Regenmortel, M. H. V. (1985) A major part of the polypeptide chain of tobacco mosaic virus protein is antigenic. EMBO J. 4, 1231-1235.
3. Giovane, C., Trav, G., Briones, A., Lutz, Y., Wasylyk, B., and Weiss, E. (1999) Targetting of the N-terminal domain of the human papillomavirus type 16 E6 oncoprotein with monomeric scFvs blocks the E6-mediated degradation of cellular p53. J. Mol. Recognit. 12, 141-152.
4. Ben Khalifa, M., Weidenhaupt, M., Choulier, L., Chatellier, J., Rauffer-Bruyère, N., Altschuh, D., and Vernet, T. (2000) Effects of mutations at the VH-VL interface of Fabs depends on the structural context. J. Mol. Recognit. 13, 127-139.
5. Christensen, L. L. (1997) Theoretical analysis of protein concentration determination using biosensor technology under conditions of partial mass transport limitation. Anal. Biochem. 249, 153-164.
6. Clark, E. B., Schwarz, E. S., and Rudolph, R. (1999) Inhibition of aggregation side reactions during in-vitro protein folding. Methods Enzymol. 309, 217-236.
7. Suenaga, M., Ohmae, H., Tsuji, S., Itoh, T., and Nishimura, O. (1998) Renaturation of recombinant human neurotrophin-3 from inclusion bodies using an aggregation suppressor. Biotechnol. Appl. Biochem. 28, 119-124.
8. Lilie, H., Schwarz, E., and Rudolph, R. (1998) Advances in refolding of proteins produced in E. coli. Curr. Opin. Biotechnol. 9, 497-501.
9. Fischer, B., Sumner, I., and Goodenough, P. (1992) Isolation and renaturation of bio-active proteins expressed in Escherichia coli as inclusion bodies. Arzneimittelforschung 42, 1512-1515.
10. Buchner, J., Pastan, I., and Brinkmann, U. (1992) A method for increasing the yield of properly folded recombinant fusion proteins: Single-chain immunotoxins from renaturation of bacterial inclusion bodies. Anal. Biochem. 205, 263-270.
11. Rogl, H., Kosemund, K., Kuhlbrandt, W., and Collinson, I. (1998) Refolding of Escherichia coli produced membrane protein inclusion bodies immobilized by nickel chelating chromatography. FEBS Lett. 423, 21-26.
12. Mihic, S. J., and Harris, R. A. (1996) Single-step purification solubilization of recombinant proteins: Application to surfactant protein B. BioTechniques 20, 804-808.
13. Werner, M. H., Clore, G. M., Gronenborn, A. M., Kondoh, A., and Fisher, R. J. (1994) Refolding proteins by gel filtration chromatography. FEBS Lett. 345, 125-130.
14. Batas, B., and Chaudhuri, J. B. (1996) Protein refolding at high concentration using size-exclusion chromatography. Biotechnol. Bioeng. 50, 16-23.